RankingsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Gross margin (%)

Fuji Pharma Co.,Ltd.【JP:4554】

Market cap
¥47.6B
P/E ratio
12.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross margin (%) YoY (%)
Sep 30, 202535.9-7.26%
Sep 30, 202438.7-4.24%
Sep 30, 202340.4-1.72%
Sep 30, 202241.1-5.31%
Sep 30, 202143.4-1.39%
Sep 30, 202044+1.08%
Sep 30, 201943.5+3.48%
Sep 30, 201842.1+1.18%
Sep 30, 201741.6+5.14%
Sep 30, 201639.5-3.40%
Sep 30, 201540.9-3.38%
Sep 30, 201442.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)